nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное общество10.28996/2618-9801-2024-3-376-379nid-715Research ArticleДИСКУССИОННЫЙ КЛУБDISCUSSIONSОтвет на комментарий Е.М. Зелтынь-Абрамова к статье «Фракция выброса левого желудочка: связь с риском смерти и частотой дисфункции артериовенозной фистулы (среднесрочные результаты)»Response to E.M. Zeltyn-Abramov's comment to the article "Left ventricular ejection fraction: association with risk of death and incidence of arteriovenous fistula dysfunction (mid-term results)"https://orcid.org/0000-0001-5405-7887ЗулькарнаевА. Б.ZulkarnaevA. B.
129110, Москва, ул. Щепкина, 61/2, корп. 6
build. 61/2 Shchepkina str., 129110 Moscow
7059899@gmail.comХирургическое отделение трансплантации почки, ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»РоссияSurgery Department of Kidney Transplantation, Moscow Regional Research and Clinical Institute ("MONIKI")Russian Federation202420092024263376379Copyright © Зулькарнаев А.Б., 20242024Зулькарнаев А.Б.Zulkarnaev A.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/715
.
.
ReferencesCr.minzdrav.gov [Internet]. Хроническая сердечная недостаточность. Клинические рекомендации. Доступно по ссылке: https://cr.minzdrav.gov.ru/schema/156_1. Дата обращения 12 июля 2024.Cr.minzdrav.gov [Internet]. Chronic heart failure. Clinical guidelines. Available at: https://cr.minzdrav.gov.ru/schema/156_1. Accessed July 12, 2024 (In Russian)Ahajournals.org [Internet]. AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation. Available at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063. Accessed July 12, 2024Ahajournals.org [Internet]. AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation. Available at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063. Accessed July 12, 2024Academic.oup.com [Internet]. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure | European Heart Journal | Oxford Academic. Available at: https://academic.oup.com/eurheartj/article/42/36/3599/6358045. Accessed 12, 2024Academic.oup.com [Internet]. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure | European Heart Journal | Oxford Academic. Available at: https://academic.oup.com/eurheartj/article/42/36/3599/6358045. Accessed 12, 2024Lok C.E., Huber T.S., Lee T. et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020. 75(4 Suppl 2):S1-S164. DOI:10.1053/j.ajkd.2019.12.001Lok C.E., Huber T.S., Lee T. et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020. 75(4 Suppl 2):S1-S164. DOI:10.1053/j.ajkd.2019.12.001Robbin M.L., Greene T., Cheung A.K. et al. Arteriovenous Fistula Development in the First 6 Weeks after Creation. Radiology. 2016. 279(2):620-629. DOI:10.1148/radiol.2015150385Robbin M.L., Greene T., Cheung A.K. et al. Arteriovenous Fistula Development in the First 6 Weeks after Creation. Radiology. 2016. 279(2):620-629. DOI:10.1148/radiol.2015150385Faaborg-Andersen C.C., Ramos C.R., Minton K. et al. Pre-existing Systolic Dysfunction is the Most Powerful Predictor of Failed Arteriovenous Fistula Maturation. Ann Vasc Surg. 2022. 87:174-180. DOI:10.1016/j.avsg.2022.01.020Faaborg-Andersen C.C., Ramos C.R., Minton K. et al. Pre-existing Systolic Dysfunction is the Most Powerful Predictor of Failed Arteriovenous Fistula Maturation. Ann Vasc Surg. 2022. 87:174-180. DOI:10.1016/j.avsg.2022.01.020Wang Q., Lin J., Han H. et al. Preoperative Cardiac Index as a Predictor of Maturation and Primary Patency of Radiocephalic Arteriovenous Fistula in Hemodialysis. Blood Purif. 2022. 51(11):932-942. DOI:10.1159/000521956Wang Q., Lin J., Han H. et al. Preoperative Cardiac Index as a Predictor of Maturation and Primary Patency of Radiocephalic Arteriovenous Fistula in Hemodialysis. Blood Purif. 2022. 51(11):932-942. DOI:10.1159/000521956Wang B., Schub M., Robinson D.L., Howell D.N. Infection as a trigger of acute, transient glomerular deposition of clonal immunoglobulins. Ultrastruct Pathol. 2024. 48(4):304-309. DOI:10.1080/01913123.2024.2356112Wang B., Schub M., Robinson D.L., Howell D.N. Infection as a trigger of acute, transient glomerular deposition of clonal immunoglobulins. Ultrastruct Pathol. 2024. 48(4):304-309. DOI:10.1080/01913123.2024.2356112Wong E., Nester C., Cavero T. et al. Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. Kidney Int Rep. 2023. 8(12):2754-2764. DOI:10.1016/j.ekir.2023.09.017Wong E., Nester C., Cavero T. et al. Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. Kidney Int Rep. 2023. 8(12):2754-2764. DOI:10.1016/j.ekir.2023.09.017Olivier C.B., Sundaram V., Chertow G.M. et al. A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation. J Vasc Access. 2020. 21(4):467-474. DOI:10.1177/1129729819887269Olivier C.B., Sundaram V., Chertow G.M. et al. A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation. J Vasc Access. 2020. 21(4):467-474. DOI:10.1177/1129729819887269Langer S., Paulus N., Koeppel T.A. et al. Cardiovascular remodeling during arteriovenous fistula maturation in a rodent uremia model. J Vasc Access. 2011. 12(3):215-223. DOI:10.5301/JVA.2010.6066Langer S., Paulus N., Koeppel T.A. et al. Cardiovascular remodeling during arteriovenous fistula maturation in a rodent uremia model. J Vasc Access. 2011. 12(3):215-223. DOI:10.5301/JVA.2010.6066Niedbalska-Tarnowska J., Jakubowska A., Majkowski M. et al. Case-inspired exploration of renin mutations in autosomal dominant tubulointerstitial kidney disease: not all paths lead to the endoplasmic reticulum. Pediatr Nephrol. 2024. 39(8):2363-2375. DOI:10.1007/s00467-024-06350-4Niedbalska-Tarnowska J., Jakubowska A., Majkowski M. et al. Case-inspired exploration of renin mutations in autosomal dominant tubulointerstitial kidney disease: not all paths lead to the endoplasmic reticulum. Pediatr Nephrol. 2024. 39(8):2363-2375. DOI:10.1007/s00467-024-06350-4Campos M.A.G., Ataídes R.J.C., Ferreira M.C. et al. Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report. Immun Inflamm Dis. 2024. 12(7):e1270. DOI:10.1002/iid3.1270Campos M.A.G., Ataídes R.J.C., Ferreira M.C. et al. Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report. Immun Inflamm Dis. 2024. 12(7):e1270. DOI:10.1002/iid3.1270Zakharova E., Nikitina E., Parshina E., Voribyeva O. A case of CFHR5 nephropathy in a patient without cypriot ancestry. Kidney International Reports. 2022. 7(6):S445-S446. DOI:10.1016/j.ekir.2022.04.039Zakharova E., Nikitina E., Parshina E., Voribyeva O. A case of CFHR5 nephropathy in a patient without cypriot ancestry. Kidney International Reports. 2022. 7(6):S445-S446. DOI:10.1016/j.ekir.2022.04.039
The authors declare that there are no conflicts of interest present.